Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel pulmonary rehabilitation approach in a 46-year-old female with significant decline in lung and functional status following H1N1.

The Journal of asthma : official journal of the Association for the Care of Asthma·2015
Same author

Eucapnic Voluntary Hyperventilation to Detect Exercise-Induced Bronchoconstriction in Cystic Fibrosis.

Lung·2015
Same author

Communication skills training curriculum for pulmonary and critical care fellows.

Annals of the American Thoracic Society·2015
Same author

Exercise-induced bronchoconstriction.

Annals of the American Thoracic Society·2014
Same author

Improving screening and diagnosis of exercise-induced bronchoconstriction: a call to action.

The journal of allergy and clinical immunology. In practice·2014
Same author

Exercise-induced bronchoconstriction.

Otolaryngologic clinics of North America·2013

Related Experiment Video

Updated: Jun 15, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Treating silent reflux disease does not improve poorly controlled asthma.

Brent P Riscili1, Jonathan P Parsons, John G Mastronarde

  • 1Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, The Ohio State University Medical Center, Columbus, USA.

Cleveland Clinic Journal of Medicine
|March 5, 2010
PubMed
Summary

Treating silent gastroesophageal reflux disease (GERD) does not improve asthma control in patients with poorly controlled asthma. This finding challenges current clinical practices and guidelines for managing asthma and GERD comorbidities.

More Related Videos

Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring
06:46

Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring

Published on: December 14, 2020

Related Experiment Videos

Last Updated: Jun 15, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring
06:46

Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring

Published on: December 14, 2020

Area of Science:

  • Pulmonology
  • Gastroenterology
  • Clinical Trials

Background:

  • Gastroesophageal reflux disease (GERD) is common in asthma patients.
  • GERD symptoms can mimic poorly controlled asthma.
  • Empirical GERD treatment is often used for asthma patients without symptomatic reflux.

Purpose of the Study:

  • To evaluate the efficacy of treating silent GERD in patients with poorly controlled asthma.
  • To determine if addressing asymptomatic GERD improves asthma outcomes.

Main Methods:

  • A randomized, placebo-controlled trial.
  • Involved patients with poorly controlled asthma and GERD.
  • Compared active GERD treatment versus placebo.

Main Results:

  • Treating silent GERD did not lead to significant improvement in asthma control.
  • No demonstrable benefit of empirical GERD treatment on asthma metrics.

Conclusions:

  • Current guidelines and clinical practices for managing asthma and GERD may need reevaluation.
  • Treating asymptomatic GERD is not recommended for improving asthma control.